InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Discover the full record of transactions filed by Hughes Owen, Director. Director active across 3 companies, notably Translate Bio, Inc.. Aggregated, 8 filings have been recorded. Total volume traded: €1.9m. The latest transaction was disclosed on 14 January 2022 — Attribution. Regulator: SEC (Form 4). The full history is openly available.
Declarations8 total
05,500 shares0
Common Stock
SEC:0001209191-22-004788·
05,500 shares0
Common Stock
SEC:0001209191-22-004788:0·
030,000 shares0
Class A Common Stock
SEC:0001213900-21-068108·
030,000 shares0
Class A Common Stock
SEC:0001213900-21-068108:0·
052,500 shares0
Class A Common Stock
SEC:0001213900-21-067727:0·
052,500 shares0
Class A Common Stock
SEC:0001213900-21-067727·
€961,18729,860 shares@ €32.1898100.0% of flow
Common Stock
SEC:0001209191-21-056049·
€961,18729,860 shares@ €32.18988.01% mcap50.0% of flow
Common Stock
SEC:0001209191-21-056049:0·
8 of 8 declarations
About Hughes Owen
Owen Hughes is a Director at Translate Bio, Inc., PARDES BIOSCIENCES, INC., and Radius Health, Inc. In this role, he participates in the governance of these companies and strategic decision-making. With significant experience in the biopharmaceutical sector, he brings valuable expertise to the leadership teams. Owen Hughes is committed to supporting the mission of these companies and fostering their growth.
